Basel, Switzerland

Werner Sieber

This inventor holds 2 USPTO granted patents. Top assignee: Ciba-Geigy Corporation. Active years: 1984.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Werner Sieber: Innovator in Photoelectrophoretic Imaging

Introduction

Werner Sieber is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of photoelectrophoretic imaging, holding a total of 2 patents. His work focuses on the use of specialized pigments that enhance imaging processes.

Latest Patents

Werner Sieber's latest patents include innovative methods for utilizing perylene and isoindoline pigments in photoelectrophoretic imaging. The first patent describes a process where a suspension of photosensitive pigment particles is subjected to an electric field and exposed to an image. This process employs perylenetetracarboxylic acid diimide pigments, which are recognized for their excellent photoelectrophoretic sensitivity and low fog density. The second patent outlines a similar imaging process using isoindoline pigments, which also demonstrate remarkable sensitivity and low fog density.

Career Highlights

Werner Sieber has been associated with Ciba-Geigy Corporation, where he has contributed to advancements in imaging technologies. His expertise in pigment chemistry has positioned him as a key figure in the development of innovative imaging solutions.

Collaborations

Throughout his career, Werner has collaborated with notable colleagues such as Max Jost and Jost Von Der Crone. These partnerships have fostered a creative environment that has led to significant advancements in their field.

Conclusion

Werner Sieber's contributions to photoelectrophoretic imaging through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field of imaging technology significantly.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…